Myomo Inc.
$1.48
$0.15 (+11.28%)
$1.31Day Range$1.51
Key Statistics
Market Cap
$58.62M
Shares Outstanding
39.6M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
Jun 12, 2017
Round Lot
100
Locale
US
Trading Data
Day Open
$1.33
Day High
$1.51
Day Low
$1.31
Volume
667.8K
VWAP
$1.46
Prev Close
$1.33
Transactions
--
Acc. Volume
--
About Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIESSIC 3842195 employees137 PORTLAND STREET, BOSTON, MA, 02114617-996-9058IPO Jun 12, 2017US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001369290
- Composite FIGI
- BBG002B0JJV6
- Share Class FIGI
- BBG002B0JJW5
- Ticker Root
- MYO
- SIC Code
- 3842
About Myomo Inc. (MYO) Stock
Myomo Inc. (MYO) closed the 2026-09-18 session at $1.48, up 11.28% versus the previous close (+0.15). The stock opened at $1.33 and traded between $1.31 and $1.51 during that session. Session trading volume was 668K shares. The volume-weighted average price (VWAP) is $1.46.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
Myomo Inc. has a market capitalization of $58.6 million. The company operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry classification. MYO is listed on the XASE exchange. The company employs approximately 195 people. Myomo Inc. is headquartered in BOSTON, MA. The recorded listing date is 2017-06-12.
On this page you can find market MYO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector.